Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018

November 8, 2018 4:10 PM EST

Reports Net Revenues of $75.5 Million for the Three Months Ended September 30, 2018

RANCHO CUCAMONGA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended September 30, 2018.

Third Quarter Highlights

Net revenues of $75.5 million for the third quarterGAAP net income attributable to Amphastar of $2.4 million, or $0.05 per diluted share, for the third quarterAdjusted non-GAAP net income attributable to Amphastar of $5.7 million, or $0.12 per diluted share, for the third quarter

Dr. Jack Zhang,... More